• 主管部门:
  • 中国科学院
  • 主办单位:
  • 中科院科技战略咨询研究院
  • 出版单位:
  • 世界科学技术杂志社
    科学出版社
  • 主编:
  • 陈凯先
  • 执行主编:
  • 胡镜清 陈士林 叶阳
  • 副主编:
  • (按姓氏笔划排列)王 伟 王 阶 王拥军 王喜军 孔令义 吕文亮 孙晓波 李 萍 李志刚 张卫东 陈立典 果德安 罗国安 赵军宁 徐宏喜 高秀梅 唐旭东 梁繁荣 葛金文
  • 名誉社长:
  • 徐伟宣
  • 社长:
  • 张志华
  • 编辑部主任:
  • 王 瑀
  • 编辑部:
  • 张娜娜 马雅静 方垚 王涵 何岸波 郭嫦娥
  • 责任译审:
  • 王晶
  • 国际刊号:
  • 1876-3553
  • 国内刊号:
  • 11-5699/R
  • 社址:
  • 北京市海淀区中关村东路55号思源楼1203
  • 邮编:
  • 100190
  • 电话:
  • 010-62616352
  • 网址:
  • www.wst.ac.cn
  • E-mail:
  • wst@casipm.ac.cn
  • 海外发行号:
  • M1644
  • 邮刊代号:
  • 2-534

鳖甲煎丸联合足三里穴位注射治疗原发性肝癌轻中度癌痛临床疗效
Clinical Effect of BieJiaJianWan and Zusanli Acupoint Point-injection on Cancer Pain of Primary Liver Cancer Patients
投稿时间:2018-01-25  修订日期:2018-03-16
DOI:
中文关键词:  原发性肝癌  癌痛  鳖甲煎丸  复方苦参注射液  穴位注射
英文关键词:Primary liver cancer  cancer pain  BieJiaJianWan(BJJW)  Compound Sophorae Injection  Point-injection
基金项目:海南省自然科学基金面上项目
作者单位E-mail
李枝锦 海口市中医医院 zhijin05@163.com 
摘要点击次数: 103
全文下载次数: 
中文摘要:
      目的:观察鳖甲煎丸联合穴位注射治疗原发性肝癌轻中度癌痛的临床疗效。方法:将80例经确诊为原发性肝癌患者随机分为对照组、治疗组,对照组轻度癌痛患者给予吲哚美辛肠溶片口服,25mg/次,3次/d,中度癌痛患者给予盐酸曲马多缓释片口服,100mg/次,2次/d。治疗组轻度、中度癌痛患者均给予鳖甲煎丸口服,3g/次,每日3次;双侧足三里穴位注射复方苦参注射液各2 ml,隔日1次。4周为一个疗程。一个疗程后,观察两组患者治疗前后疼痛评分变化,疼痛缓解率比较,治疗前后生存质量评价,治疗前后饮食量与体重变化,治疗前后肝功能、甲胎蛋白定量测定,以及记录不良反应发生情况。结果:治疗后,两组患者的疼痛评分均降低,治疗组患者的疼痛评分显著低于对照组,差异有统计学意义(P<0.05);治疗组疼痛缓解率为85%,对照组疼痛缓解率为72.5%,差异有统计学意义(P<0.05);治疗组在日常生活、情绪、行走能力、日常工作、与他人关系、睡眠、生活兴趣方面,因疼痛导致的影响均小于对照组,差异均有统计学意义(P<0.05);治疗组食量增加高于对照组,差异有统计学意义(P<0.05);治疗后两组患者体重变化治疗组小于对照组,比较差异有统计学意义(P<0.05);治疗组患者肝功能、甲胎蛋白改善均优于对照组,且差异均有统计学意义(P<0.05);治疗组不良反应发生率为30%,对照组不良反应发生率为65%,差异有统计学意义(P<0.05)。结论:鳖甲煎丸联合针刺与穴位注射治疗原发性肝癌轻中度癌痛的疗效确切,能明显改善化疗后患者的生存质量,减少不良反应发生,值得在临床上推广应用。
英文摘要:
      Objective:To observe the clinical effect of BieJiaJianWan and acupuncture with point-injection on cancer pain of Primary Liver Cancer patients. Methods:80 cases of Primary Liver Cancer patients were randomly and equally diwided into two groups.The patients of mild cancer pain in the control group were given Indometacin Enteric-coated Tablets orally(25 mg/time,tid),the patients of moderate cancer pain in the control group were given Tramadol Hydrochloride Sustained-release Tablets orally(100 mg/time,bid).The treatment group was given BieJiaJianWan orally(3 g/time,tid),acupuncture once a day,Point-injection with Compound Sophorae Injection (4 ml/time,qod). 4 weeks for a course of treatment. After a course of treatment,the score of cancer pain,effective rate of pain relief,life quality of cancer patients,nutritional status, hepatic function and alpha fetal protein test,and adverse reactions were observed and compared after the treatment cycles.Results: After the treatment, the pain scores of the patients in the two groups decreased, and the pain score of the patients in the observation group was significantly lower than that of the patients in the control group (P<0.05). The effective rates of pain relief of the patients in the observation group and the control group were respectively 85% and 72.5% (P<0.05). Nutritional status of the observation group was better than that of the control group,the differences was statistically significant(P<0.05). ?The improvement of hepatic function and alpha fetal protein test in the observation group was better than that of control group(P<0.05). The incidence rates of adverse actions in the treatment group were all lower than the control group, the observation group was 30%,the control group was 65%(P<0.05). Conclusion: BieJiaJianWan and acupuncture with point-injection could effectively relieve the cancer pain of Primary Liver Cancer patients.It could could effectively relieve the cancer pain of Primary Liver Cancer patients, improve the quality of life with less toxicity and side effects. Therefore,it is worth to be widely used clinically.
  查看/发表评论  下载PDF阅读器
关闭